SearchCME LoginCE Login Show Cart
NACE: National Association For Continuing Education 866-266-6223 9a am to 5 pm EST Mon-Fri
CME Course Description
Login to view
Course Activities.

CME Live Virtual Conferences

Go Back

Arunabh Talwar, MD, FCCP

Speaker Affiliation
Director, Pulmonary Hypertension and Advanced Lung Disease Program
North Shore University Hospital, Manhasset, New York
Professor Of Medicine
Hofstra Northwell School of Medicine
Hofstra University
Hempstead, NY

Course Director
Gregg Sherman, MD
Chief Medical Officer, NACE
Plantation, FL

Medical Writer
Josh Kilbridge
Kilbride Associates Healthcare Communications
San Francisco, CA

: The Evolving Landscape of COPD: Strategies to Optimize Care and Improve Outcomes
Activity/Course #:
: NCME344x

: Free
Release/Start Date:
: Jan 05 2018
Expiration Date:
: Jan 04 2019
: Primary Care Medicine
Target Audience:
: Primary Care Providers
: Webcast
Estimated Time To Complete CME Activity:
: 1.0 Hour
: 0
Hardware/Software Requirements:

Welcome to the National Association for Continuing Education webcast from the NACE Emerging Challenges in Primary Care 2017 conference.

Chronic obstructive pulmonary disease (COPD) is a preventable and treatable disease characterized by airflow limitation that is usually progressive and associated with an enhanced chronic inflammatory response in the airways and the lung to noxious particles or gases. The disease has a major impact on functional abilities and quality of life. COPD costs the U.S. economy an estimated $50 billion per year in healthcare expenditures and indirect costs related to morbidity and mortality, and is the third leading cause of death. Evolving international therapeutic algorithms are available to help guide clinicians diagnose COPD and select appropriate pharmacotherapy. This webcast, from the NACE Emerging Challenges in Primary Care 2017 conference, addresses these issues and provides strategies on how to provide more effective care to patients with COPD.

The webcast was recorded live and is being used with the permission of the presenter.

Learning Objective(s):

After completing this program participants should be able to:

  1. Describe strategies of care in COPD to improve diagnosis and ongoing symptom assessment
  2. Tailor COPD pharmacotherapy according to current guidelines while incorporating unique patient needs and characteristics 
  3. Discuss the appropriate use of inhaled therapies for COPD, including the importance of proper inhaler technique
  4. Collaborate with members of interprofessional health care team for effective chronic disease management

How to obtain the CME Certificate

  1. Register for the course at
  2. View the content.
  3. Complete and submit the post-test and evaluation.
  4. A minimum passing score of 70% must be earned on the post-test in order to complete the CME activity.
  5. Print your CME certificate.
Sponsored and Certified By
National Association for Continuing Education
Accreditation Designation Statement
The National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The National Association for Continuing Education designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

National Association for Continuing Education is approved as a provider of nurse practitioner continuing education by the American Association of Nurse Practitioners. AANP Provider Number 121222. This program has been approved for 1.0 contact hours of continuing education (which includes 0.75 pharmacology hours).
Faculty Disclosure Policy
Policy on Faculty and Provider Disclosure: It is the policy of the National Association for Continuing Education to ensure fair balance, independence, objectivity and scientific rigor in all activities. All faculty participating in CME activities sponsored by the National Association for Continuing Education are required to present evidence-based data, identify and reference off-label product use and disclose all relevant financial relationships. Faculty disclosures are provided below.

Arunabh Talwar, MD, FCCP serves as a speaker for Boehringer Ingelheim Pharmaceuticals.

Gregg Sherman, MD, Course Director, has no relationships to disclose.

Josh Kilbridge, Medical Writer, has no relationships to disclose.

Harvey C. Parker, Ph.D., Activity Planning Committee, has no relationships to disclose.

Michelle Frisch, MPH, Activity Planning Committee, has no relationships to disclose.

Alan Goodstat, LCSW, Activity Planning Committee, has no relationships to disclose.
Commercial Support
This educational activity is supported by an an educational grant from Sunovion Pharmaceuticals, Inc.